Article
Site-Specific Immobilization of Antibodies as a Platform Approach to Enable the Targeted Capture and Effective Removal of “Problematic” Host Cell Proteins (HCPs) from Complex Bioprocess Streams, Even at Sub-ppm Levels: Chinese Hamster Ovary (CHO) Phospholipase B-Like 2 (PLBL2)
2025-06-12
Abstract excerpt
Removal of host cell proteins (HCPs) during biotherapeutics manufacturing is vital for ensuring patient safety and biotherapeutic stability and supply. Yet, this goal remains exceptionally challenging for some HCPs. For example, phospholipase B-like 2 (PLBL2) from Chinese hamster ovary (CHO) cells (the workhorse for therapeutic protein production) plagues engineers by evading typical purification strategies. New t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9e5ad7cb-8fa0-577f-9992-483d3948c934
- DOI
- 10.22541/au.173372831.15992718/v2
